Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

NCT05379907 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT05379907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05379907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Lead sponsor
Inova Health Care Services
Phase
Observational
Overall status
Withdrawn
Start date
August 23, 2022
Completion date
August 23, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer